Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of OCT1 and CYP2D6 Genotypes on Pharmacokinetics of Berberine in Healthy Volunteers

NCT05463003 is registered in ClinicalTrials.gov with University Medicine Greifswald as lead sponsor.

NCT NCT05463003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05463003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of OCT1 and CYP2D6 Genotypes on Pharmacokinetics of Berberine in Healthy Volunteers
Lead sponsor
University Medicine Greifswald
Phase
Not applicable
Overall status
Completed
Start date
July 19, 2022
Completion date
December 31, 2022
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacokinetic study in healthy volunteers